The 4th Cell Therapy for Autoimmune Disease Summit focuses on advancing cell therapy approaches to improve precision, safety, and long-term outcomes in treating autoimmune diseases.
Key Topics
Immune cell depletion strategies for safety, persistence, and remission
Lymphodepletion balance for safety, access, and clinical impact
Target and modality innovations for future autoimmune cell therapies
Innovations in B-cell depletion and immune modulation
Next-generation antibody targeting for precision and efficacy
CAR-T and emerging modalities for therapeutic strategy
Innovations and challenges in autologous and allogeneic cell therapies
Immune cell targeting for treatment efficacy and durability
Cell therapy innovations for the future of autoimmune treatment
Preclinical and translational research
Clinical studies and applications
Strategies for patient recruitment, outcomes, and trial access
Who should Attend
Clinical researchers in autoimmune disease therapy
Biotech and pharmaceutical industry leaders
Immunologists and cell therapy scientists
Regulatory affairs professionals
Medical directors and healthcare providers
Translational medicine specialists
Venue
Sheraton Philadelphia Downtown Hotel, 201 North 17th Street, Philadelphia, Pennsylvania, United States
